Medicinal chemisrty approaches for focused search of agents for Alzheimer's disease treatment and prevention

Voprosy Meditsinskoj Khimii

Volumn 47, Issue 2, 2001, Pages 195-197

  Bachurin, S O ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

Author keywords

Alzheimer's disease; Amyloid; Cognition enhancers; Neuroprotectors

Indexed keywords

EID: 0347039407     PISSN: 00428809     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Cocabelos R., Nordberg A., Caamano J., et. al. (1994). Drugs of Today, 30, 259-337.
2. Forette F., Boiler F. (1999). In: Alzheimer's disease and related disorders. Eds. K. Iqbal, D.F. Swaab, B. Winblad and H.M. Wisniweski. J.Wiley & Sons Ltd., New York, 623-631.
3. Bartus R.T., Dean R.L., Beer B., Lippa A.S. (1982). Science. 217, 408-417.
4. Munoz F.J., Inestrosa N.C. (1999). FEBS Lett., 450, No 3,205-209.
5. Gomez-Ramos P., Moran M.A. (1997). Mol. Chem. Neuropathol., 30, No 3, 161-173.
6. Roberson M.R., Harrel L.E. (1997). Brain Research Reviews, 25, 50-69.
7. Growdon J.H. (1997). Life Sci., 60, No 13-14, 993-998.
8. Von der Kammer H., Mayhaus M., Albrecht C. et. al (1998). J. Biol. Chem., 273,14538-14544.
9. Schruder H., Wevers A. (1998). Alzheimer's Disease Reviews, 3,20-27.
10. Newhouse P.A., Kelton M. (2000). Pharm. Acta Helv. 74, 91-101
11. Kihara T., Shimohama S., Akaike A. (1999). In: Alzheimer's disease and related disorders. Eds. K. Iqbal, D.F. Swaab, B. Winblad and H.M. Wisniweski. J.Wiley & Sons Ltd., New York, pp. 715-722.
12. Schnee M.E., Brown B.S. (1998). J. Pharmacol. Exp. Ther., 286, No2, 709-717.
13. Hardy J.A. Higgins G.A. (1992). Science, 256, 184-185
14. Sabbagh M.N., Galashko D., Thal L.J. (1998). Alzheimer's Disease Review, 3, 1-19.
15. Emilien G., Beyreuther K., Masters C.L., Maloteaux J.M. (2000). Arch. Neural., 57, No4, 454-459.
16. Small D.H., McLean C.A. (1999). J.Neurochem., 73, No2, 443-449.
17. Selkoe D.J. (1996). J. Biol. Chem., 271, 18295-18298.
18. Vassar R., Bennett B.D., Babn-Khan S. et. al. (1999). Science, 286, No5440, 735-741.
19. Selkoe D.J., Wolfe M.S. (2000). Proc.Natl. Acad.Sci. USA, 97, No 11, 5690-5692.
20. Dovey H.F., John V., Anderson J.P., et al. (2001). J. Neurochem., 76, 173-181.
21. Nitsch R.M., Deng A., Wurtman R.J., Growdon J.H. (1997). J.Neurochem., 69,704-712.
22. Yanker B.A. (1996). Neuron, 16, 921-932.
23. Soto C., Sigurdsson E.M., Morelli L. et. al. (1998). Nature Med.,4, 822-826.
24. Howlett D.R., George A.R., Owen D.E. et. al (1999). Biochem J., 343, Pt.2, 419-423.
25. Soto C., Golabek A., Wisniewski T., Castano E.M. (1996). NeuroReport, 7, No3,721-725.
26. Yang D.S., Small D.H., Seydel U., Smith J.D., Hallmayer J., Gandy S.E., Martins R.N. (1999). Neuroscience, 90, No 4, 1217-1226;
27. Calera M, Rostagno A., Matsubara E. et. al. (2000); Microsc. Res. Tech. 50, 305-315
28. Schenk D, Barbour R, Dunn W. et. al (1999). Nature. 400, 173-177.
29. Frenkel D, Solomon B, Benhar I. (2000). J. Neuroimmunol., 106, No 1-2, 23-31.
30. Janus C., Pearson J., McLaurin J. et. al. 2000). Nature, 408, 979-982.
31. Morgan D., Diamond D.M., Gottschall P.E. et. al. (2000), Nature, 408,982-985.
32. Greenamyre J.T., Maragos W.F., Albin R.L. et. al. (1988). Prog. NeuroPsych. Biol. Psych., 12, No4, 421-430.
33. Doble A. (1999). Pharmacology and Therapeutics. 81, No3, 163-221.
34. Zeevalk G.D., Nicklas W.J. (1991). J. Pharmacol. Exp. Ther., 253,1285-1292.
35. Mattson M.P., Cheng B., Davis D., Bryant K, Liebeburg I., Rydel R.E. (1992). J.Neurosci., 12, 376-389.
36. Greenamyre J. T., Penney J.B., D'Amato C.J. Young A.B. (1987). J. Neurochem., 48, No2, 543-551.
37. Bleakman D., Lodge D. (1998). Neuropharmacology, 37, 1187-1204.
38. Winblad B., Poritis N. ( 1999). Int. J. Geriatr. Psychiatry, 2, 135-46.
39. Lynch G., GrangerR., Ambros-Ingerson J., Davis C.M., Kessler M., Schehr R. (1997). Experimental Neurology, 145, 89-92.
40. Bachurin S.O., Grigoriev V.V., Drany O.A., Proshin A.N., Tkachenko S.E. (1999). J. Neurochem., 73 Suppl., S143D.
41. Bachurin S.O., Bukatina E.E., Grigoriev V.V. et. al. (1998). Neurobiol. Aging, Suppl.4S, S180.
42. Holscher C., Gigg J., O'Mara S.M. (1999). Neurosci. and Biobehav. Rev., 23, 399-410.
43. Olney J.W., Wozniak D.F., Farber N.B. (1997). Arch. Neurol., 54, 1234-1240.
44. Russo C. Schettini G., Saido T.C. et. al. (2000). Nature, 405, 531-532.
45. Abe K., Kimura H. (1996). J. Neurochem., 67, 2074-2078.
46. Ueda K., Shinihara S., Yagami T. et. al. (1997). J. Neurochem., 68, 265-271.
47. Lin H., Zhu Y.J., Lal R. (1999). Biochemistry, 24, 11189-11196.
48. Durell S., Guy R., Arispe N., Rojas E., Pollard H. (1994) Biophys. J., 67, 2137-2145.
49. Behl C. (1998). Progr. Neurobiol., 57, 301-323.
50. Moosman B., Uhr M., Behl C. (1997). FEBS Lett., 413, 467-472.
51. Dore S., Bastianetto S., Kar S., Quirion R (1999). Ann New York Acad. Sci. 890,356-64.
52. Dubal D.B., Wilson M.E., Wise P.M. (1999). Alzheimer's Disease Reviews, 4, 1-9.
53. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J (2000). Maturitas, 34 Suppl 2, S35-S52
54. Gouras G.K., Xu H., Gross RS. et. al. (2000). Proc. Natl. Acad. Sci., 97, 1202-1205.
55. White S.A., Livingston F.S., Mooney R. (1999). J. Neurophysiol., 82, 2221-2234.
56. Pappolla M.A., Chyan Y.J., Poeggeler B. et. al (2000). J. Neural. Transm., 107,203-231.
57. Wolfler A., Abtija P.M., Schauenstein K., Liebmann P.M. (1999). FEBS Lett., 449, 206-210.
58. Bachurin S., Oxenkrug G., Lermontova N. et. al (1999). Ann. New York Acad. Sci., 890, 155-166
59. Lipton S.A. (1997). Nature Med., 3,20-22.
60. Lezoualc'h F., Behl C. (1999). In: Alzheimer's disease and related disorders. Eds. K. Iqbal, D.F. Swaab, B. Winblad and H.M. Wisniweski. J.Wiley & Sons Ltd., New York, pp. 698-706.
61. Deigner H.P., Kinscherf R. (1999). Current Medicinal Chemistry. 6, 399-414.
62. Sastry P. Rao K.S. (2000). J.Neurochem., 74, 1-20.
63. Kim T.W., Pettingell W.H., Jung Y.K., Kovacs D.M., Tanzi R.E. (1997). Science, 277, 373-376.
64. Nicholls D.G., Ward M.W. (2000). Trends in Neurosci. 23, 166-174.
65. Stour A.K., Raphael H.M., Kanterewicz B.I., Klann K, Reynolds I.J. (1998). Nature Neurosci., 1,366-373.
66. Marzo I, Brenner C., Zamzami N. et. al. (1998). Science. 281, 2027-2031.
67. Mather M., Rottenberg H. (2000). Biochem. Biophys. Acta, 273, p:603-608.
68. Riekkinen P. (1998). Neurobiol. Aging Suppl. 4S, abstr. No1263
69. Noble S., Wagstaff A. (1991). CNS Drugs, 8, 257-266.
70. Bennecib M., Gong C., Grundke-Iqbal I., Iqbal K. (2000). FEBS Lett. 485, 87-93.
71. Neuroinflammation Working Group. (2000). Neurobiol. Aging, 21, 383-421.
72. Aisen P.S. Davis K.L. (1997). Int. J. of Geriatric Psychopharm. 1, 2-5.